NMDAR脑炎脑脊液区室化抗体糖基谱与病因及功能恢复相关
该研究分析了50例抗NMDAR脑炎患者的配对血清和脑脊液样本,采用液相色谱-质谱法检测IgG1和IgG2/3的Fc糖基化。结果显示脑脊液抗体唾液酸化和半乳糖化显著低于血清,炎症性Fc糖型在疱疹后病例中占主导,且脑脊液和血清中唾液酸化、半乳糖化和岩藻糖化降低与1年预后不良相关。
要点
- 脑脊液抗体Fc糖型呈促炎特征,与血清存在区室差异
- 疱疹后NMDAR脑炎以炎症性Fc糖型为主,提示病毒触发机制
- 脑脊液和血清Fc糖基化降低与1年功能恢复不良相关
核心结论
- NMDAR脑炎中脑脊液Fc糖基化谱具有区室和触发因素特异性,Fc糖基化谱分析可作为潜在预后生物标志物。
研究设计与样本
- 研究纳入50例年龄和性别匹配的抗NMDAR脑炎患者,采集配对血清和脑脊液样本,按病因分为疱疹后、肿瘤相关和特发性,采用液相色谱-质谱法分析IgG1和IgG2/3的Fc糖基化。
主要发现
- 脑脊液抗体唾液酸化和半乳糖化显著低于血清(p < 0.0001),提示中枢神经系统内促炎区室化反应。
- 炎症性Fc糖型在疱疹后NMDAR脑炎中占主导(p < 0.01), compared to 肿瘤相关和特发性形式。
- 脑脊液和血清中唾液酸化、半乳糖化和岩藻糖化降低与1年预后不良相关(p < 0.05)。
关键数值与推荐
- 1年预后良好定义为改良Rankin量表(mRS)≤2,预后不良定义为≥3。
- Fc糖基化定量包括岩藻糖化、唾液酸化、半乳糖化和平分型N-乙酰葡糖胺化。
临床怎么用
- Fc糖基化谱分析可能有助于判断NMDAR脑炎病因和预测1年功能恢复。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To characterize Fc-glycosylation profiles in patients with anti-N-methyl-D-aspartate receptor encephalitis (NMDARe) and assess their association with antibody compartmentalization (cerebrospinal fluid [CSF] vs serum), disease triggers (viral, tumor-related or idiopathic), and 1-year outcomes. METHODS: We analyzed immunoglobulin (Ig) G1 and IgG2/3 Fc-glycosylation by liquid chromatography-mass spectrometry in paired serum/CSF samples from 50 age- and sex-matched patients with NMDARe identified in IDIBAPS/Hospital Clinic of Barcelona database and the Spanish study on herpes encephalitis. Patients were classified by disease trigger as post-herpetic, tumor-related, or idiopathic. One-year outcomes were defined as good (modified Rankin Scale [mRS] ≤2) or poor (≥3). Fc glycoprofiles were quantified for fucosylation, sialylation, galactosylation, and bisecting N-acetylglucosamination. RESULTS: Across IgG subclasses (IgG1-3), CSF antibodies showed significantly reduced sialylation and galactosylation compared to serum (p < 0.0001), indicating a pro-inflammatory compartmentalized response within the central nervous system. These inflammatory Fc-glycoforms were predominant in post-herpetic cases of NMDARe (p < 0.01) compared to tumor-related and idiopathic forms, suggesting that viral-induced NMDAR may alter antibody Fc-glycosylation via B-cell glycosylation pathway modulation. Furthermore, reduced sialylation, galactosylation and fucosylation in CSF and serum were associated with poor 1-year outcomes (p < 0.05), suggesting that compartmentalized inflammation and enhanced innate immune activation, including natural killer (NK) cell-mediated cytotoxicity driven by afucosylated antibodies, might contribute to neurological dysfunction. INTERPRETATION: In NMDARe, CSF Fc-glycosylation profiles are both compartment- and trigger-specific. Because glycan signatures shape innate immune interactions (e.g., with NK cells), these findings highlight distinct pathogenic mechanisms and support Fc-glycosylation profiling as a potential prognostic biomarker. ANN NEUROL 2026;99:1468-1479.
引用
- Marmolejo L, Papi C, Milano C, et al. CSF-Compartmentalized Antibody Glycoprofiles in NMDAR Encephalitis Associate with Etiology and Functional Recovery. Ann Neurol. 2026. PMID: 41708521. doi:10.1002/ana.78175
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。